MyFinsight
Home
Blog
About
Contact
Short-term investments
$122,273K
Accounts receivable, net
$49,945K
Prepaid and other
current assets
$25,746K
Cash and cash
equivalents
$24,411K
Inventories
$11,652K
Deferred income tax asset
$243,279K
Total current assets
$234,027K
Intangible assets, net
$24,160K
Other assets
$2,357K
Operating lease
right-of-use assets
$785K
Total assets
$504,608K
Total liabilities and
stockholders equity
$504,608K
Total stockholders
equity
$399,897K
Total liabilities
$104,711K
Accumulated deficit
-$1,014,387K
Accumulated other
comprehensive (loss) income
-$128K
Additional paid-in capital
$1,414,394K
Total current
liabilities
$89,492K
Long-term portion of loans
payable, net
$14,991K
Long-term portion of lease
liabilities
$228K
Common stock
$18K
Loans payable, net,
current portion
$29,865K
Revenue reserves and
refund liability
$28,080K
Other accrued
liabilities
$9,674K
Accrued compensation
$6,009K
Accrued research and
development
$5,742K
Acquisition-related liabilities
$5,000K
Accounts payable
$4,486K
Lease liabilities,
current portion
$636K
Back
Back
Balance Sheet
RIGEL PHARMACEUTICALS INC (RIGL)
RIGEL PHARMACEUTICALS INC (RIGL)
source: myfinsight.com